Physician
Gastroenterology
Dr. Maria Sjogren, MD
|
|
Give Review
Maria Sjogren practices Gastroenterology. She received 1 awards: "Fellow (FACG)". Dr. Maria Sjogren has written publications. She has 63 publications published with PubMed. The lastest publication is: 'Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Initial report of a hepatitis investigation in rural Belize.
- Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection.
- The role of chronic viral hepatitis in hepatocellular carcinoma in the United States.
- Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin.
- Dosing schedule for recombinant hepatitis B vaccine.
- Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.
- Preventing acute liver disease in patients with chronic liver disease.
- The success of hepatitis A vaccine.
- Serum angiotensin converting enzyme activity in evaluation of patients with liver disease.
- Prevention of viral hepatitis--immunoprophylaxis.
- Hepatitis B and delta hepatitis infection in Peru.
- Immunogenicity of an inactivated hepatitis A vaccine.
- Viral hepatitis--immunoprophylaxis.
- A 22-year-old man with a liver mass and markedly elevated serum alpha fetoprotein.
- Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies.
- Hepatitis C virus E2 envelope protein induces dendritic cell maturation.
- Serologic diagnosis of viral hepatitis.
- Small bile duct abnormalities in sarcoidosis.
- [Serologic response to a DNA recombinant vaccine against hepatitis B in natives of the Peruvian Amazonian jungle].
- Recombinant immunoblot assays for hepatitis C in human immunodeficiency virus type 1-infected US Navy personnel.
- Clinical significance of two forms of IgM antibody to hepatitis delta virus.
- Immune effects of alpha-interferon in chronic liver disease.
- Low-dose intradermal and intramuscular vaccination against hepatitis B.
- Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
- Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus.
- 19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage.
- Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution.
- Administration of hepatitis A vaccine to a military population by needle and jet injector and with hepatitis B vaccine.
- Replication of hepatitis B virus in adult carriers in an endemic area.
- Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections.
- Hepatic emergencies in pregnancy.
- Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection.
- [Prevention of Hepatitis A and B].
- Infection of owl monkeys (Aotus trivirgatus) and cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus from Mexico.
- Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults.
- Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine.
- Hepatitis A in the US Army: epidemiology and vaccine development.
- Acute hepatitis A: an endangered species.
- A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
- Hepatic decompensation associated with lamivudine: a case report and review of lamivudine-induced hepatotoxicity.
- IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
- Serological markers of hepatitis B virus and hepatitis D virus infections in Greek adults with primary hepatocellular carcinoma.
- Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
- Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis.
- Persistence of antibody to hepatitis B surface antigen after low-dose, intradermal hepatitis B immunization and response to a booster dose.
- Hepatitis B virus infection and hepatocellular carcinoma: correlation between IgM antibody to hepatitis B core antigen, hepatitis B e antigen, and hepatitis B DNA.
- Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
- Recurrent clinical exacerbations of liver disease during the course of infection with hepatitis C virus.
- Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial.
- Development of a live, oral, attenuated vaccine against El Tor cholera.
- Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate.
- Immunogenicity achieved by the intradermal hepatitis B vaccination programme for US Army soldiers in Korea.
- The management of HCV-infected pregnant women.
- Treatment options for HCV nonresponders and relapse patients.
- Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
- Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells.
- Antiviral response of HCV genotype 1 to consensus interferon and ribavirin versus pegylated interferon and ribavirin.
- Management of hepatitis C.
- Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination.
- Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.
- Thymalfasin: an immune system enhancer for the treatment of liver disease.
- Immunization and the decline of viral hepatitis as a cause of acute liver failure.
Schools
Facultad De Medicina De La Universidad San Fernando
Conditions Treated
- Abdominal Pain
- Cirrhosis
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Fellow (FACG)
Education
-
National University of San Marcos
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1669569497 |
| Last Name Of The Provider | SJOGREN |
| First Name Of The Provider | MARIA |
| View All |
Similar Doctors
|
|
Dr. John T. Bassett, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tim F. Greten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott L. Itzkowitz, DO |
|
|
Dr. Joseph G. Cheatham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Yao, MD |
|
|
Dr. Robert T. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. George Bolen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter N. Kaufman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael L. Weinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard L. Gelfand, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kathryn E. Kirk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajay Bakhshi, MD
This Doctor is OpenDoctor Recommended.
|